Pharmasaga is an Academia Sinica-derived biotech company, and was founded in Jan-2021. The core technology of Pharmasaga is the inhibitor of PX protein, which plays a critical role in diabetes development. Dr. Yang in Academia Sinica had researched the mechanism of diabetes for more than 20 years, and the technology of diabetes treatment was transferred to Pharmasaga for commercialization.
Company Details
- Employees
- 2
- Founded
- -
- Address
- No.99, Lane 130, Sec. 1, Academia Rd., Rm. 443,building A,taiwan, Province Of China
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.pharmasaga.com/
- Keywords
- Maxigen Biotech Inc..
- HQ
- Taipei City
Pharmasaga Questions
Pharmasaga's website is http://www.pharmasaga.com/
Pharmasaga's LinkedIn profile is https://tw.linkedin.com/company/pharmasaga
Pharmasaga has
2 employees.
View email and phone details for 2
employees at Pharmasaga.
Pharmasaga's industry is
Pharmaceutical Manufacturing
Pharmasaga's categories are Pharmaceutical Manufacturing
Pharmasaga's founding year is 2021
